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Abstract
Background: Recombinant protein production is universally employed as a solution to obtain the milligram to gram 
quantities of a given protein required for applications as diverse as structural genomics and biopharmaceutical 
manufacture. Yeast is a well-established recombinant host cell for these purposes. In this study we wanted to 
investigate whether our respiratory Saccharomyces cerevisiae strain, TM6*, could be used to enhance the productivity of 
recombinant proteins over that obtained from corresponding wild type, respiro-fermentative strains when cultured 
under the same laboratory conditions.
Results: Here we demonstrate at least a doubling in productivity over wild-type strains for three recombinant 
membrane proteins and one recombinant soluble protein produced in TM6* cells. In all cases, this was attributed to 
the improved biomass properties of the strain. The yield profile across the growth curve was also more stable than in a 
wild-type strain, and was not further improved by lowering culture temperatures. This has the added benefit that 
improved yields can be attained rapidly at the yeast's optimal growth conditions. Importantly, improved productivity 
could not be reproduced in wild-type strains by culturing them under glucose fed-batch conditions: despite having 
achieved very similar biomass yields to those achieved by TM6* cultures, the total volumetric yields were not 
concomitantly increased. Furthermore, the productivity of TM6* was unaffected by growing cultures in the presence of 
ethanol. These findings support the unique properties of TM6* as a microbial cell factory.
Conclusions: The accumulation of biomass in yeast cell factories is not necessarily correlated with a proportional 
increase in the functional yield of the recombinant protein being produced. The respiratory S. cerevisiae strain reported 
here is therefore a useful addition to the matrix of production hosts currently available as its improved biomass 
properties do lead to increased volumetric yields without the need to resort to complex control or cultivation schemes. 
This is anticipated to be of particular value in the production of challenging targets such as membrane proteins.
Background
The development of recombinant protein production sys-
tems that can be applied to a wide range of targets is a key
area of research. This is particularly true for the produc-
tion of membrane proteins, which are high value targets
in the drug discovery pipeline, and which cannot yet be
produced in high yields in a predictable manner. Griss-
hammer and Tate first addressed these issues in 1995 in
their review of the challenges of producing recombinant
membrane proteins [1]. While more recent articles have
individually covered the use of bacteria [2-5], yeasts [6],
insect cells [7], mammalian cells [8] and cell-free systems
[9] as production hosts [10,11], it is apparent that generic
solutions are still not forthcoming and that the way for-
ward should be through a rationalization of the science of
protein production [12-14].
Yeast species, especially Pichia pastoris and S. cerevi-
siae [6,11,15,16] have already been identified as one of the
most important components of a matrix of protein pro-
duction hosts [12], and have contributed a substantial
number of recombinant eukaryotic membrane proteins
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that have enabled high resolution structure determina-
tion [17-20]. We and others [21-23] have recently started
to take a more systematic approach [14] to optimise S.
cerevisiae as a host cell for recombinant protein produc-
tion. In general, a sequenced genome and well-under-
stood expression vectors with a range of promoters and
expression tags make this yeast species an attractive and
flexible option. While the P. pastoris system has a much
smaller set of vectors available and a less-well-established
molecular biology, it can be cultured to very high densi-
ties [24] potentially producing large quantities of the pro-
tein of interest. Recently we examined factors, including
pre-induction cellular biomass, affecting the total yield of
recombinant green fluorescent protein (GFP) in P. pasto-
ris [25], and noted the benefits of this as a strategy to
improve productivity. While this approach is generally
accepted to be a useful way to boost the yields of soluble
proteins, it is well established that the accumulation of
biomass does not necessarily lead to a correlated increase
in membrane protein yield [21] and in the case of G pro-
tein-coupled receptors (GPCRs), specific activity is often
lower [26]. Indeed, it has been noted that higher cell den-
sities can generate cellular stresses leading to modifica-
tions in membrane composition [27] and that this
modified environment influences the activity of recombi-
nant proteins. Consequently, medium cell density fer-
mentation procedures for GPCR expression in P. pastoris
have been suggested to be preferable to ones where bio-
mass yields are maximised [26].
Here we examined a respiratory strain of S. cerevisiae,
TM6*, which generates substantially higher biomass
yields than wild-type at the expense of ethanol formation
[28,29]. We asked whether this strain could be used as a
tool to generate improved volumetric yields of functional
proteins, especially membrane proteins. Since this strain
has an engineered phenotype, we anticipated that this
might mitigate against the cellular stress associated with
biomass accumulation in wild-type strains. In the TM6*
strain, glucose uptake is solely dependent on a chimeric
hexose transporter mediating reduced sugar uptake: the
strain was generated by integrating the gene encoding the
chimeric hexose transporter, Tm6*, into the genome of a
hexose transporter null yeast. While oxygen depletion
commonly controls the switch from respiration to fer-
mentation, in wild-type S. cerevisiae this switch also
occurs in response to the external glucose concentration.
The TM6* strain shows a fully respiratory metabolism
even at high glucose levels as seen for aerobic organisms
due to the characteristics of its chimeric hexose trans-
porter. It therefore switches to fermentation only when
oxygen is limiting.
In this study, the effectiveness of the TM6* strain as a
microbial cell factory was tested using three challenging
membrane protein targets: the eukaryotic glycerol trans-
port facilitator, Fps1 [30,31] and two recombinant human
GPCRs (the A2a adenosine receptor (A2aR) and the can-
nabinoid receptor 2 (CNR2)); as well as soluble GFP. Our
start point was to examine TM6* under conditions that
we had previously shown to give maximum recombinant
Fps1 yield for the corresponding wild-type [21] and to
compare this with the yield obtained under optimal
growth conditions. Therefore TM6* cells were cultured at
20°C, pH 5 and 30°C, pH 5, respectively. Our data show at
least a doubling in productivity over wild-type strains for
all these proteins when they are produced in TM6* cells.
In all cases, this was attributed to the improved biomass
properties of the strain. The yield profile across the
growth curve was also found to be more stable than in the
wild-type strain, and was not further improved by lower-
ing culture temperatures to 20°C, which is commonly
found for wild-type strains [21]. This has the added bene-
fit that improved yields can be attained rapidly at the
yeast's optimal growth conditions. This improved pro-
ductivity could not simply be reproduced in a wild-type
strain by culturing it under glucose fed-batch conditions
prior to glucose exhaustion. Likewise, the productivity of
TM6* was unaffected by culturing it in the presence of
ethanol.
To conclude, the beneficial properties of TM6* appear
to be unique. Consequently, TM6* should prove to be a
useful addition to the matrix of production hosts at the
disposal of modern structural biology projects, especially
for challenging targets such as membrane proteins: we
suggest that transfer of expression plasmids from wild-
type strains into TM6* is a simple way to at least double
the yield of a range of recombinant proteins.
Results
We have previously demonstrated that Fps1 is a challeng-
ing eukaryotic membrane protein target that can only be
produced in low yields in a variety of hosts (Table 1). Sub-
sequently, we demonstrated that for wild-type S. cerevi-
siae  the best yields were achieved when the culture
temperature was decreased from 30°C to 20°C and the
cells were harvested at a precise time point [21]. In this
study, we explored whether increasing the biomass yield
of S. cerevisiae cultures by simply switching to the respi-
ratory TM6* strain under the same culture conditions
could be an alternative strategy to improve productivity.
Fps1 can be produced in TM6* at the same yield per unit of 
total membrane protein as two wild-type strains
We analysed the production of recombinant Fps1 in
TM6*, which has improved biomass production proper-
ties [29], and compared it to production under identical
culture regimes in two typical wild-type strains: the wild-
type, respiro-fermentative 954 VW K70 and KOY.PK2-
1C82 strains of S. cerevisiae. The former strain was usedFerndahl et al. Microbial Cell Factories 2010, 9:47
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in our previous study [21] and the latter is derived from
CEN.PK2-1C, which is the genetic background of TM6*.
The yield of Fps1 per unit of total membrane protein was
quantified by densitometry of immunoblot signals from
75 μg total membrane protein. For quantifying Fps1 in
crude cell extracts, signals from 35 μg total cell extract
protein were used. All signals were normalised to our
previously-described internal standard [21]. Table 2
shows that when cultured at 30°C, pH5, all three hosts
gave the same average yield per unit of total membrane
protein.
On reducing the temperature of the recombinant TM6*
c u l t u r e s  t o  2 0 ° C ,  w e  n o t e d  n o  s t a t i s t i c a l l y  s i g n i f i c a n t
improvement in their productivity (data not shown). This
is in contrast to the commonly-observed increase in yield
seen on lowering culture temperatures in wild-type yeast
[21,32], as well as other recombinant hosts [14,33]. The
gas profiles (Figure 1) were similar for both 20°C, pH5
and 30°C, pH5 and showed only one phase of growth: the
small amounts of ethanol produced did not result in a
biphasic growth curve. The generation times calculated
under these conditions were 5.5 (standard error of the
mean, SEM: 0.5) h and 2.9 (0.1) h at 20°C and 30°C,
respectively. The duration of the glucose phase was sig-
nificantly longer for the 20°C culture (64.3 (9.5) h) com-
pared with that for 30°C (27.0 (2.9) h), as expected. These
temperature-dependent data are consistent with our pre-
viously-reported growth characteristics for a wild-type
strain [21]. We also noted that the lag phase for the 20°C
cultures was much more variable than for the 30°C cul-
tures (data not shown). Ethanol analysis revealed a maxi-
mum yield of 0.03 (0.02) g g-1 consumed glucose at 20°C
and 0.07 (0.02) g g-1 at 30°C, compared with a typical
value of 0.3 g g-1 for a wild-type strain at 30°C. The maxi-
mum glucose consumption rate was more than doubled
Table 2: Recombinant Fps1 yields per unit of total membrane protein are identical for two wild-type S. cerevisiae strains 
and respiratory TM6*
Fps1 yield expressed as a mean densitometry signal
Strains All samples Glucose phase Ethanol phase Stationary phase
954 VW K70 3.3 (0.3; n = 2) 3.2 (0.1; n = 2) 3.5 (0.9; n = 2) 2.6 (0.8; n = 2)
KOY.PK2-1C82 3.7 (0.6; n = 3) 3.7 (0.6; n = 3) 3.7 (0.9; n = 3) 2.5 (0.9; n = 3)
TM6* 3.1 (0.7; n = 3) 3.2 (0.8; n = 3) - 2.4 (0.9; n = 3)
Immunoblots were performed and quantified on membrane-bound fractions from two wild-type cultures and the TM6* strain, producing 
recombinant Fps1. The values given are mean densitometry signals related to our internal standard as described in the Methods section. 
Standard error of the mean, in parentheses, was calculated for replicate cultures as indicated. Note that there is no significant yield 
improvement per unit of total membrane protein for production in TM6* compared with these wild-types: increased yield is achieved on 
account of improved biomass production in TM6* (see Figure 2). Note also that since TM6* does not have an ethanol phase (-), the "stationary 
phase" samples were harvested at least 10 h after glucose exhaustion.
Table 1: Fps1 can be produced in a range of microbial cell factories
Production Host Promoter Production Localisation Reference
S. cerevisiae W301-1A GAL1 Yes tm [38]
S. cerevisiae W301-1A TPI1 Yes tm [38]
S. cerevisiae 954 VW K70 TPI1 Yes tm [21] and this study
S. cerevisiae KOY.PK2-1C82 TPI1 Yes tm This study
S. cerevisiae TM6* TPI1 Yes tm This study
P. pastoris X-33 AOX1 Yes pm [38]
P. pastoris X-33 AOX1 Yes† nd [38]
P. pastoris GS115 AOX1 Yes nd [38]
P. pastoris KM71 AOX1 Yes nd [38]
E. coli JM109 lac Yes tm [38]
E. coli JM109 T7/lac Yes tm [38]
Fps1 was produced in S. cerevisiae, P. pastoris and E. coli as previously described [21,38] and as a part of this study (tm, total membrane; pm, 
plasma membrane; nd, not determined). Note that † indicates that the α-factor signal peptide was used in the expression construct. In all cases 
prior to this study, total yields were less than 50 μg/L, which was below the threshold value for further study [21,38].Ferndahl et al. Microbial Cell Factories 2010, 9:47
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on changing the temperature from 20°C to 30°C with
rates of 2.0 (0.3) and 5.1 (0.6) mmol (glucose) g-1 (dry
weight) h-1, respectively.
Total volumetric yields of Fps1 from wild-type strains can 
be more than doubled in TM6* due to its improved biomass 
yield
When the biomass of the cultures was taken into account,
improved volumetric yields for TM6* were clearly appar-
ent compared with wild-type cells (Figure 2). At 30°C, pH
5, yields per unit of total membrane protein from glu-
cose-phase cells (at harvest points 1-3) showed more than
a 2-fold increase when comparing TM6* with wild-type
(mean values were 16.3 and 7.8 respectively; Figure 2B).
This meant that the doubling in yield we had previously
obtained by lowering the temperature of wild-type cul-
tures from 30°C to 20°C [21] had now been exceeded by
switching to the TM6* strain and culturing at 30°C.
Essentially, the highest yields were now being produced
under the optimal growth conditions: more Fps1 is pro-
duced more quickly in TM6* (generation time 2.9 h
(SEM: 0.1)) than in the previously-optimised wild-type
cultures at 20°C (generation time 8.9 h [21]).
Improved Fps1 yields in TM6* cannot be reproduced by 
culturing wild-type strains under glucose fed-batch 
conditions prior to glucose exhaustion
In an attempt to improve biomass yields for the wild-type
strain and thereby obtain improved volumetric yields as
seen in the TM6* cultures, the wild-type strain 954 VW
K70 was cultured at 30°C, pH 5 with 1 % glucose until the
glucose was depleted and then grown under glucose fed-
batch conditions. This was done in order to determine
Figure 1 Culture profiles for TM6* transformants grown aerobi-
cally on 2 % glucose. Cells were cultured at (A) 30°C, pH 5 and (B) 
20°C, pH 5. Glucose concentration (squares), OD610 (triangles) and CO2 
level (no symbol) versus time is shown for growth under these condi-
tions. The sampling points are indicated with an arrow, and each sam-
ple is also given a number for ease of identification.
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Figure 2 Fps1 yields produced from KOY.PK2-1C82 and TM6* 
cells. Samples were harvested at comparable residual glucose concen-
trations as indicated in Figure 1. (A) Immunoblots of crude cellular ex-
tracts (upper panel) of Fps1 produced in wild-type KOY.PK2-1C82 
(lanes 1-4) and TM6* cells (lanes 5-8) are shown. Lane 9 is the internal 
standard. Lanes 1-4 and 5-8 correspond to 1-Glc, 2-Glc, 3-Glc and 4-Glc, 
in Figure 2B. The marker (M) lane highlights the 98 and 62 kDa stan-
dards. The corresponding membrane fraction is shown in the lower 
panel. Wild-type cells are lanes 2, 4, 6 and 8, and TM6* cells are lanes 3, 
5, 7 and 9. Lane 1 is the internal standard. (B) The Fps1 yield per unit of 
protein was derived from immunoblots such as those shown in Figure 
2A and quantified relative to a standard for both the crude cell extract 
and membrane-bound fractions as described in the Methods section. 
The total volumetric yield was then derived by multiplying with the 
corresponding dry weights. Triplicate fermentations were used to cal-
culate the standard error of the mean (SEM).
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whether manipulating the culture regime to extend the
glucose phase of the wild-type strain would produce
higher amounts of Fps1. The substrate was fed to the cul-
ture at a rate of 2 g L-1 h-1 to a final concentration of 2 %
glucose (w/v). Figure 3A shows the profile of CO2 produc-
tion, glucose consumption and OD610, which was as
anticipated: CO2 production is essentially constant dur-
ing the glucose feed with the ethanol being respired
immediately after the glucose feed is finished, which is
seen from the second CO2 peak. Figure 3B shows that the
yield of Fps1 per unit of total membrane protein was nei-
ther sustained nor increased during the fed-batch. On the
contrary, the yield decreased with the onset of the fed-
batch, indicating that by essentially extending the glucose
growth phase, the total volumetric yield from wild-type
cells was not improved: despite having achieved very sim-
ilar biomass yields to those achieved by TM6* cultures
(Figure 1), the total volumetric yields were not concomi-
tantly increased. It was therefore clear that the simple
manipulation of culture conditions for a wild-type strain
could not mimic the properties of TM6*.
Fps1 yields in TM6* are unaffected by growing cultures in 
the presence of ethanol
We next investigated whether yields from respiratory
TM6* cells would return to wild-type levels in the pres-
ence of ethanol. TM6* was therefore cultured at 30°C, pH
5 in the presence of 2 % glucose and 7 g L-1 ethanol to
simulate the levels observed in wild type strains. Figure
4A shows that the ethanol concentration was essentially
constant through the glucose consumption phase, indi-
cating that the TM6* cells grew on glucose without any
substantial consumption of ethanol. At the point of glu-
cose depletion, the cells started to grow on the ethanol
immediately which is seen by the second CO2 peak and
the sustained increase in biomass. The total volumetric
yield of Fps1 in the cultures to which ethanol had been
added was higher than those without ethanol on account
of their higher biomass yields (Figure 4B). It was clear
however, that addition of ethanol to TM6* cultures did
not result in wild-type yields at the corresponding growth
phase (Fig 2).
Functional yields of two human GPCRs and soluble GFP are 
also increased when produced in TM6* compared with 
wild-type S. cerevisiae
Having improved the yield of Fps1 in our respiratory S.
cerevisiae strain, we wished to verify that the yields of
other recombinant proteins would also be increased com-
pared to wild-type. We therefore produced the human
GPCRs, A2aR and CNR2, in TM6* at 30°C (Figure 5). This
resulted in a doubling of the wet cell mass in TM6* (9 g
and 10 g, respectively; Table 3) compared with wild-type
cells (5 g and 4 g, respectively; Table 3) and an increase by
at least a factor of 4 in the corresponding total membrane
protein yield (5.1 mg and 5.8 mg to 23.3 mg and 29.4 mg,
respectively; Table 3). Radioligand binding experiments
for A2aR yielded respective Bmax and Kd values of 5.12
(SEM: 0.59) pmol mg-1 and 5.52 (1.68) nM for wild-type
membranes compared with 5.16 (0.61) pmol mg-1 and
6.26 (1.86) nM for TM6* membranes. The corresponding
values for CNR2 were 22.02 (4.00) pmol mg-1 and 39.75
(12.96) nM for wild-type membranes and 17.02 (2.20)
pmol mg-1 and 30.81 (7.71) nM for TM6* membranes.
These data illustrate that the yield of recombinant GPCR
per unit of total membrane protein is unchanged in the
TM6* strain, while the total functional protein yield is at
Figure 3 Analysis of protein yields for a wild-type strain grown 
under glucose fed-batch conditions in an attempt to mimic TM6*. 
(A) CO2 production (no symbol), glucose consumption (squares) and 
OD610 (triangles) show classic profiles for a fed-batch culture. Arrow 1 
indicates the onset of the feed (0 h) and arrow 6 the end (22 h). (B) An 
immunoblot (upper panel) showing the Fps1 production at 0, 1, 4, 7, 
19.5, 22 and 28 h after the onset of the feed: its quantitation (lower 
panel) is related to the internal standard.
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least quadrupled due to an increased biomass yield.
Increasing cell biomass as a strategy to increase recombi-
nant protein yield was finally verified in shake-flask cul-
tures for the soluble target, GFP. We found that yields per
unit biomass in TM6* were 600 (SEM: 30) mg L-1 OD610
-1
compared with 500 (20) mg L-1 OD610
-1 in the wild-type.
A doubling of biomass therefore led to a doubling of total
volumetric yield.
Discussion
Structural genomics projects have undertaken the impor-
tant task of characterising the hundreds of proteins that
are encoded by organismal genomes. Most recently,
membrane-protein-specific consortia have been estab-
lished such as E-MeP , MePNet, EDICT and others [34].
Typical activities include high-throughput production of
large numbers of membrane proteins, especially GPCRs
[35]. Such projects are slowly making important contri-
butions to our understanding of the structural biology of
membrane proteins (see http://blanco.biomol.uci.edu/
Membrane_Proteins_xtal.html), but by their very nature
there is a high attrition rate as individual proteins fail to
be produced using high-throughput strategies.
A current and very encouraging trend is to consider
membrane protein production as a scientific problem
that must be systematically and rationally addressed [12-
14]. We and others have contributed to this using yeast
[21,22], which has been the production host for a sub-
stantial number of recombinant eukaryotic membrane
proteins to date. As it is often desirable to obtain struc-
Figure 4 Analysis of protein yields for TM6* grown on 2 % glu-
cose in the presence and absence of ethanol. (A) CO2 production 
(no symbol), glucose consumption (squares), ethanol concentration 
(circles) and dry weights (crosses) were measured. Samples were har-
vested at the time points indicated with arrows (given numbers for the 
ease of identification). (B) The yield of Fps1 was related to the appropri-
ate dry weight for the time-point to give the total volumetric yield. At 
least duplicate fermentations were used to calculate the SEM.
Figure 5 Saturation ligand binding to membrane preparations of 
wild-type and TM6* cells producing human GPCRs. (A) Labelled 
and unlabelled ZM241385 ligands were incubated for 60 min at 25 °C 
with 10 μg cell membrane containing recombinant human A2aR. (B) 
Labelled and unlabelled CP55940 ligands were incubated for 90 min at 
30 °C with 10 μg cell membrane containing recombinant human 
CNR2. Saturation binding curves were analysed by nonlinear regres-
sion using Prism Software (GraphPad Software, USA) to calculate Bmax 
and Kd. The immunoblot signals for the corresponding proteins are 
shown as insets within the binding curves.
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tural and functional data on a specific protein, such as a
key drug target or an individual member of a biological
pathway, this absolutely warrants a systematic, tailored
approach. In our own work, we initially focused on the
glycerol facilitator from S. cerevisiae - Fps1 - on which we
have amassed a body of in vivo structure-activity data
[30,31,36,37]. Despite having constructed a good under-
standing of the gating mechanism of this intriguing pro-
tein, the ability to produce it in amounts sufficient for
structural studies has remained elusive [38] (Table 1). In
this study we therefore examined production yields in a
respiratory S. cerevisiae strain, TM6*, with improved bio-
mass-producing properties [29].
We found that the best Fps1 yield from previous studies
in wild-type yeast [21] was maintained in the TM6*
membrane in cultures grown at 30°C in batch. This is par-
ticularly advantageous since the best production condi-
tions are now the optimal growth conditions and hence
Fps1 can be produced more quickly in TM6* (generation
time 2.9 (SEM: 0.1) h) than in previously-optimised wild-
type cultures at 20°C (generation time 8.9 h) [21]. For
commercial applications, it is of utmost importance to
avoid costs associated with cooling bioreactors and to
minimise production times to maximise profit. High-
throughput platforms also significantly benefit from
shorter generation times. The biggest benefit, however,
was the total yield improvement resulting from the
improved biomass properties of TM6* compared with the
two wild-type strains without the need for complex culti-
vation regimes. In the glucose phase, maximum yields
were achieved in both wild-type strains at an OD610 of 4.5
(0.1) during batch-growth with 2 % glucose in the
medium. When we produced Fps1 in the respiratory
TM6* strain, however, maximum yields were obtained at
an OD610 of 11.0 (1.5), a 2.4-fold increase in biomass over
the wild-type. Consequently, the best yields of Fps1 from
TM6* were more than 2-fold higher than the best yields
from the wild-type strains. Interestingly, yields of Fps1
from TM6* were not further improved by lowering the
temperature, in contrast to wild-type strains where this is
routinely observed [21].
We were unable to improve yields of Fps1 in wild-type
S. cerevisiae by extending the production phase prior to
the diauxic shift (Figure 3) or to reduce yields in TM6* by
growing cultures in the presence of ethanol, mimicking
conditions found with wild-type yeast (Figure 4). We also
found that the ethanol concentration was unchanged
through the glucose consumption phase (Figure 4A)
which indicated that the TM6* cells grew on glucose
without co-consuming substantial amounts of ethanol.
As soon as the glucose was depleted, the cells started to
grow on the ethanol immediately which is seen by the
second CO2 peak and continued biomass accumulation.
We therefore concluded that the improved biomass prop-
erties of TM6*, which also enhanced the yields of three
additional recombinant proteins, could not be achieved
through simple manipulation of culture conditions.
In the related respiratory wine strain V5-TM6*P that
we have also generated [39], the genes BIO2,  BMS1,
MSD1 and RPO41 had a changed expression compared
wit h t he V5 par en t [40] and wer e also corr e la ted wit h
improved protein yields in a wild-type strain [41]. This
further strengthens our earlier observations that BMS1
plays a significant role in high yielding recombinant pro-
tein production [23]. Interestingly two subunits of the
26S proteosome subunit, RPT1 and RPT2 are also down
regulated in V5-TM6*P compared to V5 by a factor of 0.3
[40]. It is thus possible that the respiratory yeast pheno-
type has less protease activity than a wild-type strain
Table 3: Total functional yields from TM6* producing two human GPCRs are at least quadruple that from the 
corresponding wild-type transformants
Transformants Duration of 
culture (h)
Specific 
growth 
rate (h-1)
Dry cell 
weight yield 
(g g-1 Glc)
Harvest wet 
cell weight (g)
Total 
membrane 
protein yield 
(mg)
Bmax 
(pmol mg-1)
Kd (nM)
WT CNR2 16 0.3 (0.03) 0.12 (0.02) 5.0 5.1 (0.48) 22.02 (4.00) 39.75 (12.96)
WT A2aR 16 0.3 (0.03) 0.12 (0.02) 4.0 5.8 (0.19) 5.12 (0.59) 5.52 (1.68)
TM6* CNR2 25 0.2 (0.02) 0.32 (0.02) 9.0 23.3 (1.00) 17.02 (2.20) 30.81 (7.71)
TM6* A2aR 25 0.2 (0.02) 0.32 (0.02) 10 29.4 (0.98) 5.16 (0.61) 6.26 (1.86)
The human GPCRs, A2aR and CNR2, were produced in the wild-type S. cerevisiae strain, BY4741 (WT), and the respiratory strain, TM6*. Cells were 
harvested at the time points indicated for preparation of membranes for functional analysis, as described in the Methods section. The mean 
growth rate (h-1) is calculated for the exponential growth phase (n = 2). The mean dry cell weight yield is reported with respect to the glucose 
consumed (n = 2). Harvest wet cell weight is reported in g, and the mean total membrane protein yield from these cells is reported (n = 3). Bmax 
and Kd values were calculated from the curves shown in Figure 5 (n = 3). In all cases the standard error of the mean is given in parentheses.Ferndahl et al. Microbial Cell Factories 2010, 9:47
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which in turn negates the need to further slow the pro-
cess by lowering the temperature.
Overall, it is clear that yeast cells are valuable produc-
tion hosts on account of their potential for high volumet-
ric yields, short generation times and affordable media
formulations, especially in comparison with higher
eukaryotic systems. Moreover, the ability to engineer
strains with desirable properties that minimise stress
responses is straightforward in yeast. In the case of an
engineered strain such as TM6*, its improved biomass
properties, which result from its respiratory phenotype,
make it a particularly valuable resource for challenging
proteins such as membrane proteins. For example, we
r e p o r t  h e r e  t h e  f i r s t  p r o d u c t i o n  o f  f u n c t i o n a l  h u m a n
CNR2 in S. cerevisiae, and show that we can quadruple its
yield by simply switching from a respiro-fermentative to a
respiratory strain.
Conclusions
The TM6* phenotype provides a unique opportunity to
improve recombinant protein production yields in S. cer-
evisiae through biomass accumulation. Enhanced volu-
metric yields were achieved for the yeast glycerol
facilitator, Fps1, the human GPCRs, A2aR and CNR2, and
a soluble GFP. The TM6* respiratory strain should there-
fore prove to be a useful addition to the matrix of produc-
tion hosts at the disposal of modern structural biology
projects, especially for challenging proteins.
Methods
Plasmids
The FPS1 gene was tagged at its 3' end with a sequence
encoding the HA3 epitope to permit immunodetection;
the carboxy-terminal threonine residue was replaced
with the amino acid sequence: SGRIFYPYDVPDYAGY-
PYDVPDYAGYPYDVPDYAAQCGR. The HA3-tag
sequence is underlined. The construct was expressed
from the TPI promoter in the 2 μ pYX212 vector (Nova-
gen; now discontinued) which contains the URA3 selec-
tion marker. The gene was cloned into the BamH1 and
HindIII sites and the vector transformed into S. cerevisiae
TM6*, KOY.PK2-1C82 and BY4741. For the S. cerevisiae
954 VW K70 strain the construct was expressed from the
TPI promoter in the 2 μ pYX222 vector (Novagen; now
discontinued), which contains the HIS3 selection marker.
Genes encoding human A2aR and CNR2 receptors were
tagged as above at the 3' end with the HA3-tag and at the
5' end with a sequence encoding the S. cerevisiae α factor
secretion signal: MRFPSIFTAVLFAASSALAAPVNTT
TEDETAQIPAEAVIGYSDLEGDFDVAVLPFSNSTNNG
LLFINTTIASIAAKEEGVSLEKREAGS. The constructs
were expressed from the TPI  promoter in both the
pYX212 and pYX222 vectors. The pCU426 GFP construct
was the generous gift of Dr Arle Kruckeberg.
Yeast strains and growth conditions
The constructs cloned into plasmids pYX212 and
pCU426 were transformed into S. cerevisiae strains KOY-
TM6*, referred to as TM6* [42], KOY.PK2-1C82 (MATa,
ura 3-52,  MAL 2-8c  SUC2) [43] and BY4741 (MATa;
his3Δ1; leu2Δ0; met15Δ0; ura3Δ0). Constructs cloned
into plasmid pYX222 were transformed into S. cerevisiae
strain 954 VW K70 (MATα his3 SUC2 GAL MAL 2-8c).
Yeast transformants were initially grown on YNB agar
plates lacking uracil or histidine to select for plasmid
retention. For the TM6* Fps1 cultivations, 5 mL cultures
were inoculated and grown for 72 h prior to being used to
inoculate 50 mL cultures, which were grown for a period
of 24 h and used to inoculate cultures in 2.5 L to a final
OD610 of 0.05. For the wild-type cultivations, 100 mL cul-
tures were grown for 24 h before inoculating the bioreac-
tors to a final OD610 of 0.05. Yeast cells were cultured in
2.5 L 2 × CBS medium [44], with 2 % glucose as the sole
carbon and energy source. For growth of TM6* with etha-
nol in the medium, 7 g L-1 ethanol were added to the bio-
reactor together with glucose just before the inoculation.
The pH of the cultures was maintained at pH 5 using 1 M
NaOH. Polypropylene glycol P2000 was added as anti-
foam (100 μL L-1). Agitation and aeration of the cultures
were set at 1000 rpm and 0.5 vol vol-1 min-1, respectively
whilst the temperature was set at either 20°C or 30°C. The
control of the pH, agitation, aeration and temperature
was maintained online. Gas evolution was monitored on-
line (type CP460 O2/CO2, Belach Bioteknik AB).
For glucose fed-batch cultivations, the wild-type S. cer-
evisiae strain 954 VW K70 was cultured at 30°C, pH 5.
100 mL cultures were grown for a period of 24 h and used
to inoculate cultures in 2.5 L bioreactors to a final OD610
of 0.1. Yeast cells were cultured in 2.0 L YNB medium (1.7
g L-1 YNB (Q-Biogene), 5 g L-1 (NH4)2SO4) with 1 % glu-
cose until glucose was depleted, and then grown with a
feed of 500 mL 10 % glucose at a flow rate of 20 mL h-1.
Polypropylene glycol P2000 was added as antifoam (100
μL L-1). Agitation of the cultures was set at 600 rpm and
airflow of 0.6 L min-1. All cultivations were at least dupli-
cated. We have previously developed a series of simple
functional in vivo assays for aquaporins in yeast [6] (and
references therein), and hence were able to confirm that
the Fps1 was active under these conditions. Fps1 activity
in wild-type yeast was previously reported [21], and there
were no indications of any differences in this study.
BY4741 or TM6* transformed with the GPCR con-
structs were initially grown on YNB plates lacking uracil
to verify plasmid retention. Single colonies were then
used to inoculate 50 mL 2 × CBS medium and cultured
for a period of 24-48 h. These pre-cultures were then
used to inoculate 500 mL 2 × CBS medium in a bioreac-
tor to a final OD610 nm of 0.05 and cultured until glucoseFerndahl et al. Microbial Cell Factories 2010, 9:47
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depletion was detected using a Accu-Chek active glucose
analyser (Roche diagnostics, UK) according to the manu-
facturer's instructions. Cells were harvested by centrifu-
gation at 5, 000 × g, 4°C, 5 min.
BY4741 or TM6* transformed with the GFP construct
were grown on YNB plates lacking uracil to verify plas-
mid retention. Single colonies were then used to inocu-
late 50 mL YNB medium and cultured for a period of 48
h. These seed cultures were then used to inoculate fresh
50 mL YNB medium in shake-flasks containing 0 or 1
mM CuSO4 to a final OD610 of 0.15 and cultured for a
period of 24 h. Cells were harvested by centrifugation at
5, 000 × g, 4°C, 5 min.
Protein, cell dry weight and extracellular substrate 
determination
Samples for optical density measurements were taken
periodically to measure growth. For the wild-types and
ethanol-phase TM6* cultures, additional samples for sub-
sequent protein, dry weight, and extracellular substrate/
product analysis were taken out at early, mid and late glu-
cose phase (1-3-Glc) corresponding to a glucose concen-
tration of 1.5 %, 1.0 % and 0.8 % respectively, 4-Glc (when
the glucose is depleted), and 5-EtOH and 6-Stat during
the ethanol and stationary phases, 6.5 h, and 18.5 h after
glucose depletion, respectively. The same procedure was
performed for the TM6* cultures but also at additional
time points. Therefore Glc 1-3 correspond to glucose
concentrations above 1.5 %, 1.5-0.5 % and below 0.5 %,
respectively. 4-Glc corresponds to glucose exhaustion
and the stationary phase samples, 5-Stat, for the TM6*
cultures are samples taken at least 10 h after glucose
exhaustion. For extracellular substrate analysis, samples
(2 × 1 mL) were collected, and the supernatant recovered
by centrifugation (13, 000 × g for 1 min) and stored at -
20°C prior to analysis with Boehringer Mannheim GmbH
kits (Food Diagnostics, Stenungsund, Sweden) according
to the manufacturer's instructions. Dry weight calcula-
tions were performed by harvesting 2 × 5 mL samples in
pre-weighed, desiccated sample vials, and the cell pellet
recovered by centrifugation at 5,000 × g for 5 min, at 4°C.
The cells were subsequently washed twice with 5 mL ice-
cold MilliQ water, and recovered by centrifugation, as
above. The pellets were then dried for 24 h at 110°C, and
stored in a desiccator prior to being weighed. Samples for
protein analysis (1-4 × 50 mL) were harvested and the cell
pellet recovered by centrifugation at 5,000 × g for 5 min
at 4°C and stored at -20°C.
Membrane preparation and immunoblots
Analysis of Fps1 protein yields were performed on both
the total cellular extract and the total membrane fraction.
Cells were suspended in 20 mM Tris-HCl (pH 7.6), 100
mM NaCl, 0.5 mM EDTA, 5 % glycerol and mixed with
glass beads at a 1:1:1 ratio. The cells were agitated in a
FastPrep (Q-Biogene) at a speed of 6.5, 3 × 20 s with a 60
s incubation on ice between the pulses. Unbroken cells
were recovered by centrifugation at 500 × g for 10 min at
4°C, and the supernatant further clarified at 10,000 × g
for 30 min at 4°C. The total membrane fraction was col-
lected from this clarified supernatant by ultra-centrifuga-
tion at 100,000 × g for 90 min at 4°C. The protein
concentration was estimated using a BioRad Protein
Assay Kit with bovine serum albumin as a standard.
Immunoblotting was carried out with 35 μg of crude cell
extract and 75 μg of total membrane fraction loaded on a
7.5 % SDS polyacrylamide gel and separated at 65 V
through the stacking gel and 140 V through the separat-
ing gel for approximately 1 h. Proteins were transferred to
a nitrocellulose membrane and blocked with PBS con-
taining 5 % milk for 1 h before being probed with a mouse
monoclonal HA antibody (1:1,000) overnight in PBS con-
taining 5 % milk. After washing with PBS containing 5 %
milk the membrane was incubated with a secondary goat
anti-mouse IgG HRP conjugated antibody (1:2,500) for 1
h in PBS containing 5 % milk. The membrane was then
washed in PBS containing 5 % milk; followed by PBS con-
taining 0.1 % Tween-20 and finally with PBS. The blots
were developed with an ECL Plus Western Blotting
Detection Kit (Amersham Pharmacia) according to the
manufacturer's instructions, visualised using the Image
Reader LAS-100 (Fujifilm), and quantified using Multi
Gauge 3.0 (Fujifilm). Either total extract or the mem-
brane-bound fraction isolated from Sample 2 of a 30°C,
pH 5 wild-type culture [21] in YNB medium was used as
an internal standard, which is the yield of Fps1 during the
glucose growth phase of cells cultured at 30°C, pH 5 when
the OD610 was 1.5-3.0 and residual glucose levels were 2-5
g/L. All signals were below saturation and related to the
signal of the internal standard.
Radioligand binding on wild-type and TM6* membranes 
containing recombinant human A2aR and CNR2
Cells were washed once with ice-cold breaking buffer (50
mM sodium phosphate buffer pH7.4, 100 mM NaCl, 5 %
glycerol, 2 mM EDTA, 1 mM PMSF) and suspended to 30
% wet weight. 0.5 mm glass beads were added to the cell
suspension at a 1:1 ratio and cells broken at 4°C using a
FastPrep24 cell disrupter (MP Biomedical) with 8 cycles
of 30 s shaking and 30 s incubation on ice. Unbroken
cells/cell debris were separated from the membrane sus-
pension by centrifugation (3000 × g, 5 min, 4°C). Total
membranes were then recovered at 100,000 × g, 45 min,
4°C and suspended in membrane buffer (50 mM Tris pH
8.0, 120 mM NaCl, 20 % glycerol, 1 mM PMSF) using a
dounce homogenizer. Membrane proteins were quanti-
fied following the BCA method (Pierce, Rockford, IL,Ferndahl et al. Microbial Cell Factories 2010, 9:47
http://www.microbialcellfactories.com/content/9/1/47
Page 10 of 11
USA), using BSA as a standard and snap frozen in liquid
nitrogen prior to storage at - 80°C.
Saturation ligand binding assays were performed for
membranes containing human A2aR with [3H]ZM241385
and ZM241385 (10 μM) ligands in 50 mM Tris HCl pH
7.4, 1 mM EDTA, 10 mM MgCl2, and incubated at 25°C
for 1 h. In the case of human CNR2, [3H]CP55940 and
CP55940 (50 μM) in 50 mM Tris HCl pH 7.4, 2.5 mM
EDTA, 5 mM MgCl2, 0.5 mg ml-1 BSA were incubated at
30°C for 1.5 h. For each experiment, 10 μg of membrane
protein were incubated in triplicate with increasing con-
centrations of radioligand until equilibrium was reached
(total binding conditions). For non-specific binding
determination, similar incubations were performed in
parallel in the presence of an excess of unlabelled specific
ligand. Bound and free ligands were separated by rapid
filtration with Perkin-Elmer GF/B 96-unifilters pre-
soaked in 0.3 % polyethylenimine. The filters were
washed 3 times and the retained radioactivity measured
by liquid scintillation counting in a TopCount scintilla-
tion counter (Perkin Elmer). Saturation curves were anal-
ysed by nonlinear regression using Prism software
(Gra phPad Software, La Jolla, USA) t o determine B max
and Kd values.
GFP determination in wild-type and TM6* strains
Cells were suspended in 0.7 mL ice-cold breaking buffer
(50 mM sodium phosphate buffer pH7.4, 100 mM NaCl,
5 % glycerol, 2 mM EDTA) and glass beads added at a 1:1
ratio. Cells were disrupted in a FastPrep24 for 4 cycles of
speed 6.5, 30 s with 2 min incubation on ice between
cycles. Cell debris and unbroken cells were removed by
centrifugation at 5,000 × g, 4°C for 3 min and the super-
natant clarified and recovered at 20,000 × g, 4°C for 30
min. 150 μl of supernatant was mixed with 50 μL 1 M
potassium phosphate, pH 8.0 and loaded in triplicate in
black Nunc MaxiSorp 96-well plates. The fluorescence
was determined on a SpectraMax Gemini XS plate reader
(Molecular Devices, Wokingham, UK) with excitation
and emission wavelengths of 390 nm and 510 nm respec-
tively and a 495 nm cut-off.
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